2014
DOI: 10.1161/atvbaha.113.302088
|View full text |Cite|
|
Sign up to set email alerts
|

Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial STXBP5 and STX2

Abstract: Objective Tissue plasminogen activator (tPA), a serine protease, catalyzes the conversion of plasminogen to plasmin, the major enzyme responsible for endogenous fibrinolysis. In some populations, elevated plasma levels of tPA have been associated with myocardial infarction and other cardiovascular diseases (CVD). We conducted a meta-analysis of genome-wide association studies (GWAS) to identify novel correlates of circulating levels of tPA. Approach and Results Fourteen cohort studies with tPA measures (N=26… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
44
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 44 publications
(44 citation statements)
references
References 34 publications
0
44
0
Order By: Relevance
“…This requirement of STXBP5 for platelet exocytosis diverges from the protein's proposed role as a negative regulator in neuronal cell, neuroendocrine cell, and EC secretion (21,24,39,47). Our present data indicate that STXBP5 may be important for cardiovascular health, as echoed in recent GWAS in which STXBP5 has been linked to thrombosis (14)(15)(16)(17)(18)(19)(20).…”
Section: Discussionmentioning
confidence: 45%
See 2 more Smart Citations
“…This requirement of STXBP5 for platelet exocytosis diverges from the protein's proposed role as a negative regulator in neuronal cell, neuroendocrine cell, and EC secretion (21,24,39,47). Our present data indicate that STXBP5 may be important for cardiovascular health, as echoed in recent GWAS in which STXBP5 has been linked to thrombosis (14)(15)(16)(17)(18)(19)(20).…”
Section: Discussionmentioning
confidence: 45%
“…GWAS have linked SNPs in STXBP5 to alterations in vWF levels (14-19) and tPA levels (18). Loss of STXBP5 increases vWF release from ECs (47), but decreases tPA release (20). These results highlight potentially conflicting roles for STXBP5 in ECs, which may relate to which granules are being released.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…40 Meanwhile, some rare homozygous null mutations in IKBKB have been reported in patients with severe combined immunodeficiency, which result in IKKβ loss of expression and therefore impairment of immune activation. 41 Additionally, a reported GWAS signal near IKBKB downstream for the phenotype tissue plasminogen level is in partial LD with a coding variant in the tissue plasminogen activator (PLAT) gene (MIM, 173370) nearby, 42 which suggests that central adiposity with insulin resistance may be correlated with plasminogen activator through IKBKB. Interestingly, our results showed IKBKB rare variants were associated with reduced WHRs which suggested that they are protective against abdominal obesity (Figure 1a).…”
Section: Discussionmentioning
confidence: 99%
“…It still remains unknown the extent to which a common secretory pathway may contribute to the correlation between plasma levels of tPA and von Willebrand factor, which is estimated as r=≈0. 3,8 because the associations at STXBP5 and STX2 do not account for this covariation.…”
Section: See Accompanying Article On Page 1093mentioning
confidence: 99%